These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E. Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [Abstract] [Full Text] [Related]
5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS. Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146 [Abstract] [Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D. Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [Abstract] [Full Text] [Related]
7. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Cancer Res; 2001 Sep 15; 61(18):6716-22. PubMed ID: 11559542 [Abstract] [Full Text] [Related]
9. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF. Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139 [Abstract] [Full Text] [Related]
10. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R. Mol Carcinog; 2002 Aug 15; 34(4):187-98. PubMed ID: 12203370 [Abstract] [Full Text] [Related]
12. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Oncogene; 2002 Feb 07; 21(7):1048-61. PubMed ID: 11850822 [Abstract] [Full Text] [Related]
13. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue. Kwon MS, Kim SJ, Lee SY, Jeong JH, Lee ES, Kang HS. Oncol Rep; 2006 Jan 07; 15(1):27-32. PubMed ID: 16328031 [Abstract] [Full Text] [Related]
14. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW. Mol Carcinog; 2007 Jan 07; 46(1):24-31. PubMed ID: 16921492 [Abstract] [Full Text] [Related]
15. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. Zysman M, Saka A, Millar A, Knight J, Chapman W, Bapat B. Cancer Res; 2002 Jul 01; 62(13):3663-6. PubMed ID: 12097272 [Abstract] [Full Text] [Related]
16. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. Biochem Biophys Res Commun; 2004 Apr 16; 316(4):1156-62. PubMed ID: 15044106 [Abstract] [Full Text] [Related]
20. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Li JL, Fei Q, Yu J, Zhang HY, Wang P, Zhu JD. Ai Zheng; 2004 Sep 16; 23(9):985-91. PubMed ID: 15363188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]